Work

Subtype-specific activity in liposarcoma (LPS) patients (pts) from a phase 3, open-label, randomized study of eribulin (ERI) versus dacarbazine (DTIC) in pts with advanced LPS and leiomyosarcoma (LMS).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.11037

Authors: Sant P. Chawla, Patrick Schöffski, Giovanni Grignani, Jean-Yves Blay, Robert G. Maki, David R. D'Adamo, Matthew Guo, George D. Demetri

Institutions: Sarcoma Oncology Center, Universitair Ziekenhuis Leuven, Candiolo Cancer Institute, Centre Léon Bérard, Icahn School of Medicine at Mount Sinai, Eisai (United States), Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891974383

Cites:

Cited by: 8

Related to: 10